Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Depression

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 32 articles:
HTML format



Single Articles


    September 2025

  1. Medical news in brief: Surgeon is jailed for amputation fraud, first pill for postnatal depression, Ebola in DRC, and other stories.
    BMJ. 2025;390:r1892.
    PubMed    


    August 2025
  2. BOWIE K
    Postnatal depression: First pill treatment is approved in UK.
    BMJ. 2025;390:r1826.
    PubMed    


  3. DEAN E
    "I was suicidal"-the consultant psychiatrist opening up the conversation on postnatal depression.
    BMJ. 2025;390:r1449.
    PubMed    


    July 2025
  4. ARETOULI E, Malik M, Widmann C, Parker AM, et al
    Cognitive and mental health outcomes in long covid.
    BMJ. 2025;390:e081349.
    PubMed     Abstract available


    April 2025
  5. FRAIS T
    Finding the right treatment for severe depression.
    BMJ. 2025;389:r478.
    PubMed    


    February 2025

  6. CORRECTION: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.
    BMJ. 2025;388:r111.
    PubMed    


    October 2024
  7. NOLAN T
    CBT for postnatal depression ... and other research.
    BMJ. 2024;387:q2308.
    PubMed    


    September 2024
  8. HAUN MW, Tonnies J, Hartmann M, Wildenauer A, et al
    Model of integrated mental health video consultations for people with depression or anxiety in primary care (PROVIDE-C): assessor masked, multicentre, randomised controlled trial.
    BMJ. 2024;386:e079921.
    PubMed     Abstract available


    August 2024
  9. ZHANG Y, Wang H, Wu S, Xiao Y, et al
    Empowering new mothers in China: role of paediatric care in screening and management of postpartum depression.
    BMJ. 2024;386:e078636.
    PubMed    


  10. HSU TW, Tsai CK, Kao YC, Thompson T, et al
    Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.
    BMJ. 2024;386:e078607.
    PubMed     Abstract available


  11. WISE J
    Sixty seconds on . . . antidepression headsets.
    BMJ. 2024;386:q1784.
    PubMed    


    July 2024
  12. NJENGA C, Ramanuj PP, de Magalhaes FJC, Pincus HA, et al
    New and emerging treatments for major depressive disorder.
    BMJ. 2024;386:e073823.
    PubMed     Abstract available


    June 2024
  13. IACOBUCCI G
    Stopping antidepressants causes symptoms in one in six people, study estimates.
    BMJ. 2024;385:q1246.
    PubMed    


    May 2024

  14. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2024;385:q1024.
    PubMed    



  15. EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.
    BMJ. 2024;385:q1025.
    PubMed    


  16. METAXA AM, Clarke M
    Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.
    BMJ. 2024;385:e078084.
    PubMed     Abstract available


  17. DE GIORGI R, Ede R
    Psilocybin for depression.
    BMJ. 2024;385:q798.
    PubMed    


    April 2024
  18. WANG S, Deng CM, Zeng Y, Chen XZ, et al
    Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial.
    BMJ. 2024;385:e078218.
    PubMed     Abstract available


    March 2024
  19. FABIANO NT
    The effect of exercise on suicide in people with depression.
    BMJ. 2024;384:q609.
    PubMed    


    February 2024
  20. BELLON JA
    Exercise for the treatment of depression.
    BMJ. 2024;384:q320.
    PubMed    


  21. NOETEL M, Sanders T, Gallardo-Gomez D, Taylor P, et al
    Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials.
    BMJ. 2024;384:e075847.
    PubMed     Abstract available


  22. RUSSELL AB, Slater J, Woods N
    Regulation of the illicit drugs industry will save lives and reduce misery.
    BMJ. 2024;384:q304.
    PubMed    


  23. STUPAK R
    Reversing the rate of antidepressant prescribing: a view from Poland.
    BMJ. 2024;384:q234.
    PubMed    


    January 2024
  24. HAGATULAH N, Brann E, Oberg AS, Valdimarsdottir UA, et al
    Perinatal depression and risk of mortality: nationwide, register based study in Sweden.
    BMJ. 2024;384:e075462.
    PubMed     Abstract available


  25. BRANN E, Shen Q, Lu D
    Perinatal depression and its health impact.
    BMJ. 2024;384:p2777.
    PubMed    


    December 2023
  26. DAVIES J, Read J, Kruger D, Crisp N, et al
    Politicians, experts, and patient representatives call for the UK government to reverse the rate of antidepressant prescribing.
    BMJ. 2023;383:p2730.
    PubMed    


    September 2023
  27. CHEN CC, Shao J, Liu Y, Gao Y, et al
    A man with ST segment depression.
    BMJ. 2023;382:e076079.
    PubMed    


    August 2023
  28. MAHASE E
    US approves daily pill for postpartum depression.
    BMJ. 2023;382:p1822.
    PubMed    


    July 2023
  29. THOMBS BD, Markham S, Rice DB, Ziegelstein RC, et al
    Screening for depression and anxiety in general practice.
    BMJ. 2023;382:1615.
    PubMed    


  30. NOGRADY B
    Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics.
    BMJ. 2023;382:p1599.
    PubMed    


    June 2023
  31. WISE J
    Review that questioned serotonin theory of depression was flawed, say researchers.
    BMJ. 2023;381:1419.
    PubMed    


    March 2023
  32. IACOBUCCI G
    NICE recommends online therapies to treat depression and anxiety in adults.
    BMJ. 2023;380:p495.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Depression is free of charge.